TherapeuticsMD Inc
NASDAQ:TXMD
Income Statement
Earnings Waterfall
TherapeuticsMD Inc
Revenue
|
1.3m
USD
|
Cost of Revenue
|
0
USD
|
Gross Profit
|
1.3m
USD
|
Operating Expenses
|
-9.8m
USD
|
Operating Income
|
-8.5m
USD
|
Other Expenses
|
-1.8m
USD
|
Net Income
|
-10.3m
USD
|
Income Statement
TherapeuticsMD Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
9
N/A
|
10
+15%
|
12
+17%
|
14
+16%
|
15
+10%
|
17
+11%
|
18
+7%
|
19
+6%
|
20
+7%
|
21
+2%
|
20
-2%
|
21
+2%
|
19
-6%
|
18
-5%
|
18
-1%
|
17
-6%
|
17
-2%
|
17
-1%
|
16
-3%
|
15
-6%
|
16
+6%
|
16
+1%
|
19
+14%
|
39
+109%
|
50
+28%
|
58
+17%
|
63
+8%
|
58
-7%
|
65
+11%
|
72
+12%
|
85
+17%
|
91
+7%
|
3
-97%
|
(17)
N/A
|
(39)
-137%
|
(64)
-64%
|
70
N/A
|
2
-97%
|
2
+4%
|
2
-17%
|
1
-34%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(6)
|
(8)
|
(11)
|
(13)
|
(16)
|
(18)
|
(18)
|
(20)
|
(1)
|
3
|
6
|
11
|
(1)
|
11
|
12
|
12
|
0
|
|
Gross Profit |
7
N/A
|
8
+12%
|
9
+16%
|
10
+16%
|
11
+9%
|
13
+13%
|
14
+7%
|
15
+6%
|
16
+7%
|
16
+2%
|
15
-3%
|
16
+2%
|
15
-4%
|
15
-3%
|
15
+2%
|
14
-4%
|
14
-2%
|
14
-1%
|
14
-2%
|
13
-7%
|
13
+5%
|
13
+0%
|
15
+11%
|
34
+131%
|
43
+26%
|
50
+15%
|
51
+3%
|
45
-12%
|
49
+9%
|
55
+12%
|
67
+23%
|
71
+6%
|
1
-98%
|
(14)
N/A
|
(33)
-135%
|
(53)
-61%
|
69
N/A
|
14
-80%
|
14
+3%
|
14
0%
|
1
-91%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(33)
|
(37)
|
(44)
|
(56)
|
(65)
|
(79)
|
(96)
|
(99)
|
(101)
|
(101)
|
(95)
|
(101)
|
(105)
|
(105)
|
(104)
|
(93)
|
(92)
|
(95)
|
(108)
|
(127)
|
(144)
|
(157)
|
(167)
|
(179)
|
(195)
|
(224)
|
(219)
|
(210)
|
(204)
|
(188)
|
(191)
|
(210)
|
(81)
|
(54)
|
(15)
|
31
|
(58)
|
21
|
33
|
46
|
(10)
|
|
Selling, General & Administrative |
(19)
|
(20)
|
(20)
|
(21)
|
(22)
|
(23)
|
(25)
|
(26)
|
(29)
|
(32)
|
(36)
|
(44)
|
(51)
|
(59)
|
(63)
|
(60)
|
(58)
|
(62)
|
(76)
|
(95)
|
(116)
|
(130)
|
(142)
|
(157)
|
(174)
|
(196)
|
(203)
|
(197)
|
(193)
|
(178)
|
(182)
|
(202)
|
(81)
|
(56)
|
(18)
|
26
|
(58)
|
(34)
|
(23)
|
(10)
|
(9)
|
|
Research & Development |
(13)
|
(18)
|
(24)
|
(35)
|
(43)
|
(55)
|
(71)
|
(73)
|
(72)
|
(69)
|
(59)
|
(57)
|
(54)
|
(47)
|
(41)
|
(33)
|
(34)
|
(33)
|
(31)
|
(32)
|
(27)
|
(27)
|
(25)
|
(22)
|
(20)
|
(17)
|
(15)
|
(12)
|
(10)
|
(9)
|
(8)
|
(8)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
0
|
(1)
|
(0)
|
(0)
|
(1)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(10)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
4
|
6
|
0
|
56
|
56
|
56
|
0
|
|
Operating Income |
(26)
N/A
|
(30)
-16%
|
(35)
-18%
|
(46)
-30%
|
(54)
-18%
|
(66)
-22%
|
(82)
-25%
|
(84)
-2%
|
(85)
-1%
|
(85)
0%
|
(79)
+7%
|
(85)
-7%
|
(90)
-6%
|
(91)
0%
|
(89)
+2%
|
(79)
+12%
|
(78)
+2%
|
(81)
-4%
|
(94)
-16%
|
(114)
-21%
|
(130)
-14%
|
(144)
-10%
|
(152)
-6%
|
(145)
+5%
|
(151)
-4%
|
(174)
-15%
|
(167)
+4%
|
(165)
+1%
|
(156)
+6%
|
(134)
+14%
|
(124)
+7%
|
(139)
-12%
|
(80)
+43%
|
(68)
+14%
|
(48)
+30%
|
(22)
+53%
|
11
N/A
|
35
+228%
|
47
+35%
|
60
+27%
|
(9)
N/A
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(3)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(3)
|
(5)
|
(7)
|
(10)
|
(14)
|
(17)
|
(22)
|
(25)
|
(27)
|
(29)
|
(33)
|
(33)
|
(33)
|
0
|
(15)
|
(8)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(10)
|
(10)
|
(10)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(9)
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
3
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
26
|
25
|
25
|
(0)
|
(100)
|
(100)
|
(100)
|
1
|
|
Pre-Tax Income |
(28)
N/A
|
(31)
-10%
|
(36)
-16%
|
(46)
-28%
|
(54)
-17%
|
(66)
-22%
|
(82)
-25%
|
(84)
-2%
|
(85)
-1%
|
(85)
0%
|
(79)
+7%
|
(85)
-7%
|
(90)
-6%
|
(90)
0%
|
(89)
+2%
|
(78)
+12%
|
(77)
+2%
|
(80)
-4%
|
(94)
-17%
|
(115)
-22%
|
(133)
-16%
|
(148)
-11%
|
(170)
-15%
|
(166)
+2%
|
(176)
-6%
|
(194)
-10%
|
(190)
+2%
|
(191)
0%
|
(184)
+4%
|
(166)
+10%
|
(157)
+6%
|
(172)
-9%
|
(79)
+54%
|
(58)
+27%
|
(30)
+48%
|
3
N/A
|
1
-61%
|
(65)
N/A
|
(53)
+19%
|
(40)
+25%
|
(8)
+80%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(28)
|
(31)
|
(36)
|
(46)
|
(54)
|
(66)
|
(82)
|
(84)
|
(85)
|
(85)
|
(79)
|
(85)
|
(90)
|
(90)
|
(89)
|
(78)
|
(77)
|
(80)
|
(94)
|
(115)
|
(133)
|
(148)
|
(170)
|
(166)
|
(176)
|
(194)
|
(190)
|
(191)
|
(184)
|
(166)
|
(157)
|
(172)
|
(79)
|
(58)
|
(30)
|
3
|
1
|
(65)
|
(53)
|
(39)
|
(8)
|
|
Net Income (Common) |
(28)
N/A
|
(31)
-10%
|
(36)
-16%
|
(46)
-28%
|
(54)
-17%
|
(66)
-22%
|
(82)
-25%
|
(84)
-2%
|
(85)
-1%
|
(85)
0%
|
(79)
+7%
|
(85)
-7%
|
(90)
-6%
|
(90)
0%
|
(89)
+2%
|
(78)
+12%
|
(77)
+2%
|
(80)
-4%
|
(94)
-17%
|
(115)
-22%
|
(133)
-16%
|
(148)
-11%
|
(170)
-15%
|
(166)
+2%
|
(176)
-6%
|
(194)
-10%
|
(190)
+2%
|
(191)
0%
|
(184)
+4%
|
(166)
+10%
|
(157)
+6%
|
(172)
-9%
|
(172)
-1%
|
(182)
-6%
|
(27)
+85%
|
(9)
+68%
|
112
N/A
|
157
+41%
|
43
-73%
|
68
+60%
|
(10)
N/A
|
|
EPS (Diluted) |
-9.8
N/A
|
-10.77
-10%
|
-12.41
-15%
|
-15.22
-23%
|
-18.13
-19%
|
-20.15
-11%
|
-23.77
-18%
|
-23.69
+0%
|
-24.58
-4%
|
-21.82
+11%
|
-20.09
+8%
|
-21.5
-7%
|
-22.92
-7%
|
-22.75
+1%
|
-21.79
+4%
|
-18.83
+14%
|
-18.71
+1%
|
-18.51
+1%
|
-21.64
-17%
|
-25.14
-16%
|
-29.47
-17%
|
-30.64
-4%
|
-35.21
-15%
|
-34.39
+2%
|
-35.75
-4%
|
-35.63
+0%
|
-34.97
+2%
|
-35.02
0%
|
-33.29
+5%
|
-23.92
+28%
|
-19.88
+17%
|
-20.32
-2%
|
-21.66
-7%
|
-21.14
+2%
|
-3.09
+85%
|
-0.93
+70%
|
11.95
N/A
|
16.14
+35%
|
4.18
-74%
|
6.38
+53%
|
-0.98
N/A
|